Tangible evidence for a key role of complement in AD was provided in 2009, when two independent GWAS studies identified genes encoding clusterin and CR1 (and later C1S and C9) as significant risk factors to develop AD (139, 140, 176). This evidence concerns the gene C1S and Alzheimer disease.